Lutetium-177 and Actinium-225 are emerging as pivotal isotopes in cancer treatment, particularly for metastatic prostate cancer. Lutetium-177 offers targeted radiotherapy,…
Nanoparticle-based drug delivery promises targeted treatment, improving precision medicine by delivering therapeutics directly to diseased tissues while minimizing harm to…